Search

everythinglearnresearchcommunity

for

Search:↓

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Both follicular unit extraction and scalp expanders effectively treat secondary cicatricial alopecia, with scalp expanders leading to quicker and denser hair growth.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Preventive measures during surgery can avoid hair loss complications.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Baricitinib is effective and safe for treating severe alopecia areata.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Scalp-to-scalp skin grafts quickly heal and hide well under regrown hair, making them good for repairing large scalp defects.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Primary care should recognize and treat hair loss in hijab-wearing individuals with cultural sensitivity.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Warfarin can rarely cause hair loss, which is usually reversible.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

The belief about hair shedding phases is likely incorrect and needs reevaluation.